144 related articles for article (PubMed ID: 7669829)
1. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.
Hausberger AG; DeLuca PP
J Pharm Biomed Anal; 1995 May; 13(6):747-60. PubMed ID: 7669829
[TBL] [Abstract][Full Text] [Related]
2. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
3. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
[TBL] [Abstract][Full Text] [Related]
4. Co-effect of aqueous solubility of drugs and glycolide monomer on in vitro release rates from poly(D,L-lactide-co-glycolide) discs and polymer degradation.
Kim JM; Seo KS; Jeong YK; Hai BL; Kim YS; Khang G
J Biomater Sci Polym Ed; 2005; 16(8):991-1007. PubMed ID: 16128233
[TBL] [Abstract][Full Text] [Related]
5. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers.
Elkheshen SA; Radwan MA
J Microencapsul; 2000; 17(4):425-35. PubMed ID: 10898083
[TBL] [Abstract][Full Text] [Related]
6. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin release from poly(D,L-lactide) and poly(lactide-co-glycolide) disks.
Ozalp Y; Ozdemir N; Hasirci V
J Microencapsul; 2002; 19(1):83-94. PubMed ID: 11811762
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of therapeutics from microporous membranes. II. In vitro degradation and release of heparin-loaded poly(D,L-lactide-co-glycolide).
Kreitz MR; Domm JA; Mathiowitz E
Biomaterials; 1997 Dec; 18(24):1645-51. PubMed ID: 9613812
[TBL] [Abstract][Full Text] [Related]
9. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
Engwicht A; Girreser U; Müller BW
Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
[TBL] [Abstract][Full Text] [Related]
10. Sterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storage.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
J Microencapsul; 2004 Sep; 21(6):653-65. PubMed ID: 15762322
[TBL] [Abstract][Full Text] [Related]
11. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior.
Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH
Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197
[TBL] [Abstract][Full Text] [Related]
12. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery.
Chowdhury DK; Mitra AK
Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
Schrier JA; DeLuca PP
Pharm Dev Technol; 1999; 4(4):611-21. PubMed ID: 10578516
[TBL] [Abstract][Full Text] [Related]
15. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
16. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
Shiga K; Muramatsu N; Kondo T
J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
Kostanski JW; Thanoo BC; DeLuca PP
Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
[TBL] [Abstract][Full Text] [Related]
18. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
Park TG
Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787
[TBL] [Abstract][Full Text] [Related]
19. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
Boisdron-Celle M; Menei P; Benoit JP
J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
